Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvants in Bilevel ESP Block for Mastectomy
NCT05591417Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2022
- Primary completion
- Sep 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine and dexamethasone in postoperative pain (4 arms), sponsored by National Cancer Institute. Primary endpoint: Total morphine consumption in the first 24 hours postoperatively. Started Oct 2022; status: completed.
02
Drugs
dexmedetomidinedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05591417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05591417.